白塞病相关性眼病的研究进展(3)
[10]Mendes D,Correia M,Barbedo M,et 's diseasea contemporary review[J].J Autoimmun,2009,32(3-4):178-188.
[11]刘晋林,唐桂兰,李双娟.白塞病眼型的临床分析[J].中华风湿病学杂志,2002,6:2.
[12]Gul A.Behcet′s di sease:An updat e on the path ogen esis[J].Clin Exp Rheumatol,2001,19:6-12.
[13]Kilmartin DJ,Finch A,Acheson association of HLAB51 with Behcet's disease in Ireland[J].Br J Ophthalmol,1997,81:649-653.
[14]Imamura Y,Kurokawa MS,Yoshikawa H,et of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet’s disease[J].Clin Exp Immunol,2005,139:371-378.
[15]Deniz E,Guc U,Buyukbabani N,et al.HSP 60 expression in recurrent oral ulcerations of Behcet’sdisease[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2010,110:196-200.
[16]Smith JR,Hart PH,Coster DJ,et al.Mice deficient in tumor necrosis factor receptors p55 and p75,interleukin-4,or inducible nitric oxide synthase are susceptible to endotoxin-induced uveitis[J].Invest Ophthalmol Vis Sci,1998,39(3):658-661.
[17]Pineton de Chambrun M,Wechsler B,Geri G,et al.New insights into the pathogenesis of Behcet's disease[J].Autoimmun Rev,2012,11(10): 687-698.
[18]Lee RW,Dick concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation[J].Eye(Lond),2012, 26(1):17-28.[19]Qin of DR3 expression in CD4(+) T cells promotes secretion of IL-17 in experimental autoimmune uveitis[J].Mol Vis,2011,17:3486-3493.
[20]De Vos AF,Klaren VN,Kijlstra of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat[J].Invest Ophthalmol Vis Sci,1994,35(11):3873-3883.
[21]Khan MA,Haroon M,Rosenbaum JT.Acute anterior uveitis and spondyloarthritis:more than meets the eye[J].Curr Rheumatol Rep,2015, 17(9):59.
[22]Nanke Y,Kotake S,Goto M,et percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before Ocular attack:Apossible predictive marker of ocular attack[J].Mod Rheumatol,2008,18(4):354-358.
[23]Takeuchi M,Usui Y,Okunuki Y,et responses to inter photo receptor retinoid-binding proteinand S-antigen in Behcet’s patients with uvetis[J].Invest Ophthalmol Vis Sci,2010,51:3067-3075.
[24]杨永升,张美芬,庄曾渊.葡萄膜炎复发原因调查[J].协和医学杂志,2013,(2):150-153.
[25]Natkunarajah M,Kaptoge S,Edelsten C.Risks of relapse in patients with acute anterior uveitis[J].Br J Ophthalmol,2007, 91(3): 330-334.
[26]Wechsler B,Lê Thi Huong DB,Saadoun D.EULAR recommendations for the management of Behcet's disease:Evidence-based or experience-based medicine[J].Rev Med Interne,2009,30(11):939-941.
[27]Zagora SL,Mccluskey P.Ocular manifestations of seronegativespondyloarthropathies[J].CurrOpinOphthalmol,2014,25(6):495-501.
[28]Alunno A,ManettiM,CaterbiS, immunoregulation in rheumatoid arthritis:The role of regulatory t cells and proinflammatory th17 cells and therapeutic implications[J].Mediators Inflamm,2015,2015:.
[29]Prete M,Dammacco R,Fatone MC,et uveitis:Clinical,pathogenetic,and therapeutic features[J].Clin Exp Med,2016,16(2):125-136.
[30]Hatemi G,Seyahi E,Fresko I,et 's syndrome:a critical digest of the 2013-2014 literature[J].Clin Exp Rheumatol,2014,32:112-122.
文章来源:《中国生物制品学杂志》 网址: http://www.zgswzpxzz.cn/qikandaodu/2021/0514/530.html
上一篇:齐长庆中国生物制品事业创始人
下一篇:家禽养殖中病毒性疾病的应对思路